Page 216 - 2019_01-Haematologica-web

A. Laghmouchi et al.
cific precursor T cells and regulatory T cells.
Haematologica. 2011;96(8):1204-1212.
37. Wehler TC, Nonn M, Brandt B, et al. Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines. Blood. 2007;109(1):365-
373.
38. Lam TS, van de Meent M, Falkenburg JF,
Jedema I. Monocyte-derived dendritic cells can induce autoreactive CD4(+) T cells showing myeloid lineage directed reactivity in healthy individuals. Eur J Immunol. 2015;45(4):1030-1042.
39. Rutten CE, van Luxemburg-Heijs SA, van der Meijden ED, et al. HLA-DPB1 mis- matching results in the generation of a full repertoire of HLA-DPB1-specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles. Biol Blood Marrow Transplant. 2010;16(9):1282-1292.
40. Sizzano F, Zito L, Crivello P, et al. Significantly higher frequencies of alloreac- tive CD4+ T cells responding to nonpermis- sive than to permissive HLA-DPB1 T-cell epitope disparities. Blood. 2010;116(11): 1991-1992.
41. Rutten CE, van Luxemburg-Heijs SA, van
der Meijden ED, et al. Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro. Blood. 2010;115(1):151-153.
42. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol. 2003;21:139-176.
43. Herr W, Eichinger Y, Beshay J, et al. HLA- DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation. Leukemia. 2017;31(2):434- 445.
206
haematologica | 2019; 104(1)